Janux Therapeutics Inc (JANX)
56.71
-0.04
(-0.07%)
USD |
NASDAQ |
Dec 20, 16:00
56.81
+0.10
(+0.18%)
After-Hours: 20:00
Janux Therapeutics Shareholders Equity (Quarterly): 656.10M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rezolute Inc | 113.44M |
| Vir Biotechnology Inc | 1.241B |
| Cytokinetics Inc | -13.91M |
| Galectin Therapeutics Inc | -92.48M |
| Spero Therapeutics Inc | 65.51M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 695.02M |
| Total Liabilities (Quarterly) | 38.92M |
| Current Ratio | 38.80 |